MedTrace Logo

Art Therapy in Acute Schizophrenia

NCT01622166 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2014-10-24

No results posted yet for this study

Summary

Randomised, controlled, single-blinded pilot study to assess the efficacy of psychodynamic art therapy in a sample of hospitalized, (sub)acutely psychotic patients with a diagnosis of schizophrenia compared to a group of patients receiving treatment as usual.

\*Main hypothesis: Art therapy has no impact on clinical symptoms and the course of remission compared to TAU.

\*Exploratory hypotheses: Art therapy has no influence on quality of life, mentalizing function, self-efficacy and neuroleptic dosage compared to TAU.

Conditions

Interventions

BEHAVIORAL

psychodynamic art therapy

2 sessions à 1.5 hrs /week, intervention duration 6 weeks

Sponsors & Collaborators

  • Prof. K. Dannecker, Kunsttherapie Berlin Kunsthochschule Berlin-Weißensee

    collaborator UNKNOWN

  • Charite University, Berlin, Germany

    lead OTHER

Principal Investigators

  • Christiane Montag, M.D. · Charite University, Berlin, Germany

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2013-01-31
Completion
2013-01-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01622166 on ClinicalTrials.gov